Phase Ib Study of Dovitinib in Combination With Gemcitabine Plus Cisplatin or Gemcitabine Plus Carboplatin in Patients With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 24 Jun 2015
At a glance
- Drugs Dovitinib (Primary) ; Carboplatin; Cisplatin; Gemcitabine
- Indications Solid tumours
- Focus Adverse reactions
- 01 Sep 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Dec 2011 New trial record